Loading
Latest filing published 23 Apr 2026 for ProMIS Neurosciences Inc., €39k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Patrick D. Kirwin appears in our data through filings on ProMIS Neurosciences Inc. shares, published by SEC (Form 4). In total, 8 filings cover trades dated from 17 August 2022 to 22 April 2026.
The open-market record is one-sided, with 6 purchases worth €91k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants. So far in 2026, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €9,896. On 3 out of 6 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 23 April 2026, the filings show an open-market purchase worth €39k in ProMIS Neurosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations